Indoco Remedies Board of Directors
Get the latest insights into the leadership at Indoco Remedies. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Suresh G Kare | Chairman |
| Ms. Aditi Panandikar | Managing Director |
| Mr. Sundeep V Bambolkar | Joint Managing Director |
| Dr. Anand Nadkarni | Non Executive Director |
| Mr. Satish Shenoy | Independent Director |
| Mr. Ajay Mulgaokar | Independent Director |
| Dr.(Ms.) Vasudha V Kamat | Independent Director |
| Mr. Abhijit Y Gore | Independent Director |
Indoco Remedies Share price
INDOCO
273.1
8.65 (-3.07%)NSE
BSE
Last updated on 4 Sep, 2025 | 15:45 IST
BUYSELL
Today's High
286.70
Today's Low
271.10
52 Week Low
190.00
52 Week High
387.55
The current prices are delayed, login to your account for live prices
LoginIndoco Remedies FAQs
The board at Indoco Remedies consists of experienced professionals, including Mr. Suresh G Kare , Ms. Aditi Panandikar , and others, overseeing the company’s strategic and corporate governance.
Directors at Indoco Remedies are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Suresh G Kare is the current chairman at Indoco Remedies.
Executive directors at Indoco Remedies are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Indoco Remedies adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Indoco Remedies, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.